Fundz

Fulcrum Therapeutics Appoints Isabel Kalofonos as Chief Commercial Officer and Heather Faulds as Chief Regulatory Affairs & Quality Assurance Officer

PUBLIC · FULCAug 19, 2024

Position

Chief Regulatory Affairs Officer

Company

Fulcrum Therapeutics

Heather Faulds
hfaulds@fulcrumtx.com
CambridgeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Fulcrum Therapeutics announced the appointment of Isabel Kalofonos as chief commercial officer and Heather Faulds as chief regulatory affairs & quality assurance officer. Both will play vital roles in advancing losmapimod towards a New Drug Application (NDA) submission and the preparation for commercial launch.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Fulcrum Therapeutics, and when

A new leader at Fulcrum Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Fulcrum Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Fulcrum Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Fulcrum Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Fulcrum Therapeutics

Location

ONE KENDALL SQUARE

Cambridge, Massachusetts, United States

About

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Fulcrum Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Patrick
Likely contact at this company
••••••••@••••••••

See Patrick's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Fulcrum Therapeutics's next move

Learn about Strategic plan

Fulcrum Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.